Novel thiosemicarbazide-oxadiazole hybrids as unprecedented inhibitors of yeast α-glucosidase and in silico binding analysis

Compounds 1-18, new oxadiazole-thiosemicarbazide hybrids, were synthesized using a five-step reaction sequence in excellent yields. All the synthesized analogs exhibited exceptional α-glucosidase inhibitory potentials in the range of 0.4-38.1 μM. Among the current series, it was observed that the fl...

Full description

Bibliographic Details
Published in:RSC Advances
Main Author: Taha M.; Ismail N.H.; Imran S.; Wadood A.; Ali M.; Rahim F.; Khan A.A.; Riaz M.
Format: Article
Language:English
Published: Royal Society of Chemistry 2016
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84964523904&doi=10.1039%2fc5ra28012e&partnerID=40&md5=aa6dbb8465ae9ee063c8c7663e2f2783
Description
Summary:Compounds 1-18, new oxadiazole-thiosemicarbazide hybrids, were synthesized using a five-step reaction sequence in excellent yields. All the synthesized analogs exhibited exceptional α-glucosidase inhibitory potentials in the range of 0.4-38.1 μM. Among the current series, it was observed that the fluoro-substituted analogues were exceptionally potent inhibitors of α-glucosidase. The study provides a proof of concept that inductively strong electron withdrawing groups result in enhanced inhibitory potentials. The binding interactions of these compounds were analyzed in silico for possible prediction and identification of the improved inhibitory potential. © The Royal Society of Chemistry 2016.
ISSN:20462069
DOI:10.1039/c5ra28012e